This inventor holds 28 USPTO granted patents and 6 published patent applications and 1 EPO patent, primarily in GSK-3 Inhibitors. Top assignees: Astrazeneca Ab, Astra Aktiebolag, Astex Therapeutics Limited. Active years: 2000-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ekero, SE (2000 - 2003)
- Ekerö, SE (2001 - 2008)
- Södertälje, SE (2006 - 2010)
- Sodertalje, SE (2009 - 2010)
Company Filing History:
26 out of 1,534 
2 out of 271 
1 out of 126 
Years Active: 2000-2010
Areas of Expertise:
Title: Innovations and Contributions of Stefan Berg in Pharmaceutical Chemistry
Introduction
Stefan Berg, a prominent inventor based in Södertälje, Sweden, holds an impressive portfolio of 28 patents. His work primarily focuses on pharmaceutical compounds and their applications in treating neurodegenerative diseases and cognitive impairments. Berg's contributions to the field of medicinal chemistry demonstrate the impactful intersection of innovation and healthcare.
Latest Patents
Among Berg's latest patents are novel compounds aimed at treating cognitive impairment, Alzheimer’s Disease, neurodegeneration, and dementia. The first invention relates to new compounds described by specific structural formulas and their pharmaceutically acceptable salts, along with compositions and usage methods. Another of his notable patents involves 3-heterocyclyl-indole derivatives acting as inhibitors of glycogen synthase kinase-3 (GSK-3). The compounds detailed in this patent comprise various structural components, including salts and pharmaceutical formulations, intended for therapeutic applications.
Career Highlights
Throughout his career, Stefan Berg has made significant strides in pharmaceutical research, particularly while working with AstraZeneca AB and Astra Aktiebolag. His scientific work and patent development are focused on creating innovative solutions that address complex health issues, marking him as a notable figure in the industry.
Collaborations
Berg has collaborated with esteemed colleagues such as Svante Bertil Ross and Seth-Olov Thorberg. Their collective expertise has undoubtedly enhanced the research environment and fostered an atmosphere conducive to innovation at their respective organizations.
Conclusion
Stefan Berg’s pursuit of innovative pharmaceutical solutions, demonstrated through his extensive patent portfolio, showcases the vital role inventors play in advancing medicine and improving patient outcomes. His work on compounds for cognitive impairment and neurodegeneration exemplifies a commitment to addressing pressing health challenges through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile